About Mosaic Biosciences
Mosaic Biosciences is a private company based in Boulder, Colorado. It has reported $14,687,459 raised in three offerings on Form D since July 2011. Its chief executive is Martin Stanton.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 2022 | Jan 6, 2023 | $11,382,997of $11.3M target | 4 | $2.8M | EquityRule 506(b) | Form D ↗ |
| Jan 28, 2014 | Feb 10, 2014 | $2,274,000of $2.3M target | 4 | $568K | EquityRule 506(b) | Form D ↗ |
| Jul 7, 2011 | Jul 20, 2011 | $1,030,462fully sold | 7 | $147K | Equity06 | Form D ↗ |
| Total, three offerings | $14,687,459 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mosaic Biosciences's Form D filed Jan 6, 2023.
RC
Rob Capone
Director
JW
Jeanette Welsh
Director
DM
Dan Mitchell
Director
MS
Martin Stanton
CEO and director
EF
Eric Furfine
Director
Earlier filings also listed Nassim Usman (director, last listed Feb 2014), Mark Lupa (director, last listed Feb 2014), Guy Katsav (director, last listed Feb 2014) and Augustine Lawlor (director, last listed Feb 2014).